LISOCABTAGENE MARALEUCEL for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 56 adverse event reports in the FDA FAERS database where LISOCABTAGENE MARALEUCEL was used for Product used for unknown indication.
Most Reported Side Effects for LISOCABTAGENE MARALEUCEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 315 | 42.7% | 48 | 189 |
| Immune effector cell-associated neurotoxicity syndrome | 129 | 17.5% | 22 | 74 |
| Neurotoxicity | 101 | 13.7% | 7 | 68 |
| Pyrexia | 47 | 6.4% | 3 | 37 |
| Fatigue | 38 | 5.2% | 2 | 9 |
| Hypotension | 38 | 5.2% | 8 | 26 |
| Febrile neutropenia | 28 | 3.8% | 2 | 26 |
| Confusional state | 27 | 3.7% | 1 | 22 |
| Death | 25 | 3.4% | 25 | 5 |
| Lymphocyte adoptive therapy | 25 | 3.4% | 4 | 19 |
| Malignant neoplasm progression | 23 | 3.1% | 13 | 10 |
| Platelet count decreased | 23 | 3.1% | 8 | 5 |
| Tremor | 22 | 3.0% | 1 | 13 |
| Aphasia | 21 | 2.9% | 1 | 16 |
| Neutropenia | 21 | 2.9% | 5 | 11 |
Other Indications for LISOCABTAGENE MARALEUCEL
Diffuse large b-cell lymphoma (347)
B-cell lymphoma (57)
Chronic lymphocytic leukaemia (47)
Follicular lymphoma (38)
Mantle cell lymphoma (25)
Diffuse large b-cell lymphoma refractory (21)
Diffuse large b-cell lymphoma recurrent (16)
Non-hodgkin's lymphoma (15)
Marginal zone lymphoma (10)
B-cell lymphoma refractory (8)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)